Growth hormones and factors in surgical patients.
Herndon
D N
DN
Shriners Burns Institute-Galveston, Texas.
Hayward
P G
PG
Rutan
R L
RL
Barrow
R E
RE
D000818:Animals; D002986:Clinical Trials as Topic; D003115:Colony-Stimulating Factors / Q000502:physiology; D004921:Erythropoietin / Q000502:physiology / Q000627:therapeutic use; D005346:Fibroblast Growth Factors / Q000502:physiology; D013006:Growth Hormone / Q000502:physiology / Q000627:therapeutic use; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007378:Interleukins / Q000502:physiology; D009369:Neoplasms / Q000503:physiopathology; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D016211:Transforming Growth Factor alpha / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology; D014945:Wound Healing / Q000502:physiology*
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D007378:Interleukins; D010982:Platelet-Derived Growth Factor; D011994:Recombinant Proteins; D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; D004921:Erythropoietin; D005346:Fibroblast Growth Factors; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone